Resonance Health Seeks Survey Participants

September 8, 2009 – Resonance Health, the Australia-based company which has developed the FerriScan technology (also called R2 MRI), for the measurement of iron overload, is asking thalassemia patients and clinicians to participate in online surveys.

Below is the information that Resonance Health forwarded to CAF about these surveys, which we are supplying to the thalassemia community for those who may be interested.

From Resonance Health:

“We would very much appreciate your assistance in a 2 minute survey to find out more about current clinical practice in iron monitoring and management of thalassemia patients in the US.

“Just click on the links below to fill in this short survey.

“Thalassemia patients click here for the survey.

“Clinicians click here for the survey.

“Thank you for your valuable support.”

Secured By miniOrange